Adult
Aged
Antineoplastic Agents
Carcinoma, Transitional Cell
Cisplatin
Combined Modality Therapy
Disease-Free Survival
Female
Humans
Male
Middle Aged
Prospective Studies
Radiotherapy Dosage
Survival Rate
Urinary Bladder Neoplasms
